|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This site is dedicated to Cindi McCain & Lou Grubb: Friends & Stroke Survivors....(ALLOW 1 MINUTE TO LOAD)....We search 100's of internet sites for daily news: New York Times, Washington Post, LA Times, Chicago Tribune, Harvard, Yale, UCLA, CNN, FOX, CBS, NBC, ABC, BBC, Journal of American Medical Assoc., New England Journal of Medicine, Mayo Clinic, Johns Hopkins Medicine, Cleveland Clinic, Memorial Sloan- Kettering, Reuters & 100's more...(WE DO NOT ACCEPT ADVERTISING) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
FridayIndependent Online Edition > Business News
Independent Online Edition > MORE: "AstraZeneca, the UK's No2 drug maker, has agreed to pay up to $1 billion to buy a new pill that could dramatically cut the risk of heart attacks and strokes in people with clogged arteries. The company is taking an initial $50 million bet on the experimental drug being developed by a US firm, AtheroGenics, and has agreed to further payments that could total $300 million as the drug is approved and another $650 million if it beats ambitious sales targets........."
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||